Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for nuclear factor kappa b
Most Correlated Studies
- L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
- L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
- L1000 CMAP - Carcinoma of prostate VCAP cells treated with ligand perturbagens
- L1000 CMAP - Non-small cell lung cancer HCC515 cells treated with ligand perturbagens
- L1000 CMAP - Carcinoma of prostate PC3 cells treated with ligand perturbagens
Most Relevant Literature
- Caffeic Acid Phenethyl Ester Attenuates Dextran Sulfate Sodium-Induced Ulcerative Colitis Through Mo…
- Mechanistic insight into the synergism of IL-27 and IL-28B in regulation of benzo(a)pyrene-induced l…
- Downregulation of activating transcription factor 4 attenuates lysophosphatidycholine-induced inflam…
- Nesfatin-1 inhibits free fatty acid (FFA)-induced endothelial inflammation via Gfi1/NF-κB signaling.
- Progress and Prospects of Non-Canonical NF-κB Signaling Pathway in the Regulation of Liver Diseases.
Most Relevant Clinical Trials
- Nuclear Factor Kappa-B (NFKB1) Polymorphism and Organ Injury After Cardiac Surgery
- Impact of the Rapid Normalization of Chronic Hyperglycemia and the Practice of Moderate Physical Act…
- B Cell Functions in Periodontitis
- Changes of GCF Levels of RANKL and Osteoprotegerin in Postmenopausal Osteoporosis
- Feasibility Study Of Adding Bortezomib to R-ICE Chemotherapy To Treat Relapsed/ Refractory Diffuse L…
